Ads
related to: Abbvie- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
Search results
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 1 day agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
AbbVie-bound Cerevel reports phase 3 Parkinson's victory in early win for $8.7B deal
FierceBiotech· 23 hours agoThe backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in...
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 22 hours agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
The Wall Street Journal· 19 hours agoAbbVie’s acquisition of neuroscience biotech Cerevel Therapeutics hasn’t closed yet. Notably, when ...
AbbVie's Upadacitinib shows promise in giant cell arteritis study By Investing.com
Investing.com· 20 hours agoThe study met both its primary endpoint and key secondary endpoints, with a higher percentage of...
Is AbbVie a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoBig pharma stocks like AbbVie (NYSE: ABBV) usually aren't high on the list that investors look to for opportunities that could make them into...
Abbvie Inc [ABBV] Shares Rise 1.05 % on Wednesday – Knox Daily
Knox Daily· 1 day agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abbvie Inc shares valued at $3,716,757 were sold by Donoghoe ...
AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment (ABBV)
Seeking Alpha· 18 hours agoAnalyst’s Disclosure: I/we have a beneficial long position in the shares of ABBV either through...
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 2 days agoThe latest trading session saw AbbVie (ABBV) ending at $164.25, denoting a +1.05% adjustment from...
Counterfeit Botox linked to illnesses in nine states
The Independent US via AOL· 20 hours agoCounterfeit Botox shares similarities to the FDA-approved Botox manufactured by AbbVie. However, Botox made by AbbVie displays their product description...
Ad
related to: Abbvie
